A Study to Evaluate the Efficacy and Safety of LNK01004 Ointment in Adults With Atopic Dermatitis

NCT07071610 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: LNK01004 ointment 0.3%
DRUG: LNK01004 ointment 1.0%
DRUG: Vehicle

Sponsor

Lynk Pharmaceuticals Co., Ltd